Human epidermal growth factor receptor 2 expression in women with uterine cervix adenocarcinoma from Appalachian Kentucky

INTRODUCTION: High-risk human epidermal growth factor receptor 2 (HER2)-positive adenocarcinomas associate with early recurrence and death, prompting consideration of novel radiotherapeutic options like a trastuzumab-linked thorium-227 alpha-particle emitting radionuclide. METHODS: We conducted a re...

Descripción completa

Detalles Bibliográficos
Autores principales: Kunos, Charles A., Fabian, Denise, Piecoro, Dava W., Napier, Dana, Miller, Rachel W., Ueland, Frederick R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902924/
https://www.ncbi.nlm.nih.gov/pubmed/36761943
http://dx.doi.org/10.3389/fonc.2023.948348

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902924/
https://www.ncbi.nlm.nih.gov/pubmed/36761943
http://dx.doi.org/10.3389/fonc.2023.948348

Ejemplares similares